Jeff Andrews, MD -- Associate Professor of Medical Education, Associate Professor of OB/GYN, & Senior Fellow, Vanderbilt Center for Evidence-Based Medicine, Vanderbilt University

Dr. Jeff Andrews has appointments as associate professor of medical education, associate professor of OB/GYN, and is senior fellow of the Vanderbilt Center for Evidence-Based Medicine. In conjunction with the VCEBM, Dr. Andrews is participating in the integration of evidence-based medicine with clinical orders and pathways in clinical care; expansion of EBM within the curriculum; and applied EBM research. Dr. Andrews served as vice president and then as chief medical officer for EBM Solutions, creating evidence-based guidelines and tools for use by providers and patients on the Internet. Before Vanderbilt, Dr. Andrews spent 11 years at Duke University Medical Center. His leadership roles at Duke included associate professor, division chief, medical director of women's services, medical director of OB/GYN quality improvement and performance improvement, medical director of DukeHealth Internet initiative, and clinical advisor for evidence-based medicine guidelines. Prior to joining Duke University Medical Center, Dr. Andrews practiced in Canada for five years. Dr. Andrews completed his internship and residency in Obstetrics and Gynecology at the University of Toronto. Dr. Andrews received his medical degree from the University of Toronto in Toronto, Ontario, Canada. He is board certified by the Royal College of Physicians and Surgeons of Canada and is a fellow of the American College of Obstetricians and Gynecologists. Dr. Andrews is a member of numerous international organizations, including Cochrane Collaborative Review Groups, Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group, Guidelines International Network (G-I-N), Society for Medical Decision Making, and Appraisal of Guidelines Research and Evaluation (AGREE).

Disclosures: Dr. Andrews has nothing to disclose.

Allan Gibofsky, MD, JD -- Professor of Medicine & Public Health, Weill Medical College of Cornell University

Dr. Allan Gibofsky is professor of medicine and public health at the Weill Medical College of Cornell University, professor of law at Fordham University and adjunct faculty at the Rockefeller University. He is an attending physician and rheumatologist at the Hospital for Special Surgery and New York-Presbyterian Hospital. Dr. Gibofsky has authored and co-authored numerous papers and text chapters, primarily on the immunogenetics of rheumatic diseases and legal aspects of medical practice. Dr. Gibofsky is known for his work on mechanisms of host-microbe interactions in rheumatology, and, in particular for his basic and clinical studies on rheumatic fever. Dr. Gibofsky received his undergraduate degree from Brooklyn College of the City University of New York, his medical degree from Weill Medical College of Cornell University and his law degree from Fordham University. He completed his internship in pathology, followed by a residency in medicine at New York Hospital. Dr. Gibofsky completed a fellowship in Rheumatology/Immunology jointly at the Hospital for Special Surgery and The Rockefeller University.

Disclosures: Dr. Gibofsky has disclosed that he has served as a consultant and served on the speakers bureaus for Abbott, Amgen, Bristol-Myers Squibb, Wyeth and Pfizer.

John D. Hainsworth, MD -- Chief Scientific Officer, Sarah Cannon Research Institute

As chief scientific officer for the Sarah Cannon Research Institute, Dr. John D. Hainsworth is responsible for the scientific progress of the SCRI, including protocol development, data analysis and manuscript preparation. Dr. Hainsworth has a variety of clinical research interests and has published extensively in the areas of lung cancer, unknown principal cancer, breast cancer and lymphoma. He has concentrated his research on expanded roles and innovative uses for several new drugs, including docetaxel, gemcitabine, rituximab and bevacizumab. Dr. Hainsworth received his medical degree from Vanderbilt University and his Bachelor of Arts degree from Stanford University.

Disclosures: Dr. Hainsworth disclosed he has received grant and research support from Genentech, Biogen Idec, Eli Lilly, Pfizer, Novartis and Amgen.

David Johnson, MD -- Cornelius Abernathy Craig Professor in Medical and Surgical Oncology and Deputy Director of the Vanderbilt-Ingram Cancer Center

Dr. David H. Johnson is the Cornelius Abernathy Craig Professor in Medical and Surgical Oncology and Deputy Director of the Vanderbilt-Ingram Cancer Center. He graduated from the Medical College of Georgia in 1976, joined the Vanderbilt faculty upon completion of his oncology fellowship in 1983 and was appointed Director of the Division of Hematology and Medical Oncology in 1991. He is a board-certified internist and medical oncologist, a widely recognized investigator in the fields of lung and breast cancer, the author of over 300 publications, editor or co-editor of numerous oncology textbooks and serves on the editorial boards of numerous internal medicine and cancer journals. In 2004/2005, Dr. Johnson served as the 41st President of the American Society of Clinical Oncology (ASCO), the world's largest organization of cancer specialists. Currently, he is a member of the Boards of Directors of the American Board of Internal Medicine (ABIM), the Lance Armstrong Foundation and the International Association for the Study of Lung Cancer. He is also chairman of the ABIM Oncology Subspecialty Certification Board. Dr. Johnson has been named to numerous “Best Doctor” lists over the past 25 years including Woodward & White's Best Doctors in America, Woodward & White's Best Cancer Doctors in America, America's Top Doctors, and Good Housekeeping magazine's list of the country's top oncologists for women. In 2006 he received the Southern Association of Oncology's Distinguished Oncologist Award, the Association of Community Cancer Centers Clinical Research Award in 2007 and the ASCO Statesman Award in 2008.
Disclosures: Dr. Johnson has nothing to disclose.

David J. Maron, MD, FACC -- Associate Professor of Medicine & Emergency Medicine, Vanderbilt University, Director, Vanderbilt Chest Pain Center, Medical Director, Dayani Health & Wellness Center

Dr. David J. Maron received his bachelor's degree from Stanford University and his medical degree from the University of Southern California School of Medicine in 1981. He completed his residency at the University of California, Los Angeles Medical Center in 1984. He was a Robert Wood Johnson Clinical Scholar and cardiology fellow at Stanford University. He is board-certified in internal medicine and in cardiovascular diseases. Dr. Maron's patient care and clinical research emphasis at Vanderbilt is preventive cardiology, lipid disorders and ischemic heart disease.

David N. Neubauer, MD -- Associate Director, Johns Hopkins Sleep Disorders Center

Dr. David N. Neubauer is associate director of the Johns Hopkins Sleep Disorders Center and an assistant professor in the department of psychiatry at the Johns Hopkins University School of Medicine. Dr. Neubauer is also the medical director of the Psychiatry Mobile Treatment Program at the Johns Hopkins Bayview Medical Center. He earned his bachelor's and master's degrees at Florida Atlantic University. He earned his medical degree at the University of Miami School of Medicine, and completed his psychiatry internship and general psychiatry residency at Johns Hopkins Hospital.

Disclosures: Dr. Neubauer has disclosed he has served as a consultant and/or has received lecture fees from Neurocrine Biosciences, Pfizer, Sanofi-Aventis and Takeda Pharmaceuticals.

Kimberly Rask, MD, PhD -- Director, Emory Center on Health Outcomes and Quality; Associate Professor of Health Policy and Management, Rollins School of Public Health and Emory University School of Medicine

Dr. Kimberly Rask directs the Emory Center on Health Outcomes and Quality and is associate professor of health policy and management with joint appointments in the Rollins School of Public Health and the Emory University School of Medicine. Dr. Rask is a clinically active general internist and has served as clinical advisor and editor-in-chief to an academic medical center consortium developing Web accessible evidence-based clinical practice guidelines. Her research focuses on health promotion and outcomes measurement. She has published book chapters and peer-reviewed articles on primary care practice, cost-effectiveness, performance improvement and outcomes measurement. Her current research projects include: evaluating the cost-effectiveness of behavioral interventions to prevent the transmission of HIV infections; evaluating the use of Web accessible clinical practice guidelines in primary care practices; improving health outcomes for patients with diabetes in primary care settings; and evaluating the use of a pharmacy IT system to identify hospitalized patients at risk for adverse events. Dr. Rask received her doctorate in health economics from the Wharton School of the University of Pennsylvania and her medical training at the University of Pennsylvania. She is a fellow of the American College of Physicians.

Disclosures: Dr. Rask has nothing to disclose.

Todd Schwedt, MD -- Assistant Professor of Neurology, Director of the Washington Headache Center, Washington University School of Medicine, St. Louis

Dr. Todd Schwedt specializes in the treatment and study of headache disorders. His research interests include headache and intracranial aneurysms, thunderclap headaches and reversible cerebral vasoconstriction, right-to-left shunt and migraine, objective measures of studying pain outcomes, and migraine-associated dizziness. Dr. Schwedt obtained his medical degree from the University of Missouri School of Medicine. He completed his medical internship and neurology residency at The Cleveland Clinic Foundation as well as a headache fellowship at Mayo Clinic.

Disclosures: Dr. Schwedt has disclosed he has received grant and research support from GlaxoSmithKline, AGA Medical, Allergan and the National Institutes of Health.